What should we expect from a bioartificial liver in fulminant hepatic failure?

被引：16
|
作者：
Bismuth, H [1 ]
Figueiro, J
Samuel, D
机构：
[1] Hop Paul Brousse, Fac Med Paris Sud, Ctr Hepatobiliaire, F-94800 Villejuif, France
[2] Assistance Publ Hop Paris, Ctr Hepatobiliaire, Villejuif, France
来源：
ARTIFICIAL ORGANS | 1998年 / 22卷 / 01期
关键词：
fulminant hepatitis; liver transplantation; bioartificial liver;
D O I：
10.1046/j.1525-1594.1998.06059.x
中图分类号：
R318 [生物医学工程];
学科分类号：
0831 ;
摘要：
Fulminant hepatic failure is associated with high mortality. Liver transplantation is an effective therapy that improves survival, and because of donor organ shortage and urgency, a bioartificial liver could act as an effective bridge to liver transplantation in patients with fulminant hepatic failure. We discuss the place of the bioartificial liver in the treatment of other causes of liver failure.
引用
收藏
页码：26 / 31
页数：6
相关论文
共 50 条
  • [41] Omalizumab: what benefits should we expect?
    Ana Giménez-Arnau
    Manel Velasco
    Jose Carlos Armario Hita
    Moises Labrador-Horrillo
    Juan Francisco Silvestre Salvador
    European Journal of Dermatology, 2016, 26 : 340 - 344
  • [42] Crisis Management: What Should We Expect?
    Veech, Annette
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 63 - 63
  • [43] Omalizumab: what benefits should we expect?
    Gimenez-Arnau, Ana
    Velasco, Manel
    Armario Hita, Jose Carlos
    Labrador-Horrillo, Moises
    Silvestre Salvador, Juan Francisco
    EUROPEAN JOURNAL OF DERMATOLOGY, 2016, 26 (04) : 340 - 344
  • [44] MICROPROCESSOR CONSULTANTS - WHAT SHOULD WE EXPECT
    WESTON, R
    CONTROL AND INSTRUMENTATION, 1982, 14 (01): : 33 - &
  • [45] Evaluation of a bioartificial liver based on nonwoven fabric bioreactor with porcine hepatocytes in fulminant hepatic failure pigs
    不详
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2005, 28 (09): : 928 - 928
  • [46] PLASMA CYTOKINE LEVELS IN PATIENTS WITH FULMINANT HEPATIC-FAILURE (FHF) TREATED WITH A BIOARTIFICIAL LIVER (BAL)
    ROSEN, HR
    LEBOW, LT
    LEPAGE, E
    VIERLING, JM
    DEMETRIOU, AA
    GASTROENTEROLOGY, 1994, 106 (04) : A971 - A971
  • [47] Bioartificial liver (BAL) treatment prevents development of intracranial hypertension in pigs with fulminant hepatic failure.
    Khalili, TM
    Navarro, A
    Ting, P
    Arkadopoulos, N
    Kamohara, Y
    Mullon, CJP
    Demetriou, AA
    Rozga, J
    HEPATOLOGY, 1998, 28 (04) : 171A - 171A
  • [48] An experimental large animal model for the assessment of bioartificial liver support systems in fulminant hepatic failure.
    Ytrebo, LM
    Nedredal, GI
    Revhaug, A
    HEPATOLOGY, 2001, 34 (04) : 194A - 194A
  • [49] What oil export levels should we expect from OPEC?
    Gately, Dermot
    ENERGY JOURNAL, 2007, 28 (02): : 151 - 173
  • [50] Liver transplantation for fulminant hepatic failure
    David H. Van Thiel
    John Brems
    Abdul Nadir
    Ramazan Idilman
    Alessandra Colantoni
    David Holt
    Steven Edelstein
    Journal of Gastroenterology, 2001, 36 : 1 - 4
12345